LKB1 Mutation Status is Associated with Poor Radiation Outcome in Patients with Non-Small Cell Lung Cancer

被引：0
|
作者：
Sitthideatphaiboon, P. [1 ]
Cobo, A. [2 ,3 ]
Poteete, A. [2 ,3 ]
Zhang, F. [2 ,3 ]
Lui, D. [4 ]
Rinsurongkawong, W. [5 ]
Heymach, J. [6 ]
机构：
[1] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Div Med Oncol, Dept Med,Fac Med, Bangkok, Thailand
[2] Univ Texas MD Anderson Canc Ctr, Dept Thorac Oncol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Med Oncol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[6] Univ Texas MD Anderson Canc Ctr, Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Liver Kinase B1; Kelch-like ECH-Associated Protein 1; Radio-resistance;
D O I：
10.1016/j.jtho.2018.08.1705
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.03-28
引用
收藏
页码：S921 / S921
页数：1
相关论文
共 50 条
  • [1] Impact of LKB1 status on radiation outcome in patients with stage III non-small-cell lung cancer
    Sitthideatphaiboon, Piyada
    Nantavithya, Chonnipa
    Chantranuwat, Poonchavist
    Vinayanuwattikun, Chanida
    Sriuranpong, Virote
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [2] Impact of LKB1 status on radiation outcome in patients with stage III non-small-cell lung cancer
    Piyada Sitthideatphaiboon
    Chonnipa Nantavithya
    Poonchavist Chantranuwat
    Chanida Vinayanuwattikun
    Virote Sriuranpong
    Scientific Reports, 14
  • [3] STK11/LKB1 mutation in non-small cell lung cancer: Prognostic or predictive?
    Rosellini, P.
    Girodet, P. O.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 50 - 51
  • [4] LKB1 loss is associated with resistance to VEGF inhibitors in non-small cell lung cancer (NSCLC)
    Guijarro, Irene
    Poteete, Alissa
    Yang, Chao
    Roarty, Emily
    Nilsson, Monique
    Sun, Huiying
    Tong, Pan
    Chang, Edward
    Rodriguez-Canales, Jaime
    Mino, Barbara
    Parra, Edwin
    Wistuba, Ignacio
    Wang, Jing
    Heffernan, Timothy
    Heymach, John V.
    CANCER RESEARCH, 2016, 76
  • [5] LKB1 as the keyregulator of non-small cell lung cancer plasticity and therapeutic response
    Science Foundation in China, 2015, (03) : 15 - 15
  • [6] PREDICTIVE VALUE OF LKB1 IN PATIENTS WITH RESECTED NON SMALL CELL LUNG CANCER
    Fabre, E.
    Pecuchet, N.
    Laurent-Puig, P.
    Pallier, K.
    Le Pimpec-Barthes, F.
    Riquet, M.
    Cazes, A.
    Blons, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 77 - 77
  • [7] Unraveling the Role of STK11/LKB1 in Non-small Cell Lung Cancer
    Sumbly, Vikram
    Landry, Ian
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
  • [8] LOSS OF LKB1 IS ASSOCIATED WITH RESISTANCE TO IFN-GAMMA AND T CELL KILLING IN NON-SMALL CELL LUNG CANCER
    Reuben, Alexandre
    Jiang, Peixin
    Nie, Hui
    Cobo, Ana Galan
    Dang, Minghao
    Qian, Yu
    Frank, Meredith
    Blitz, Emily
    Hamdi, Haifa
    Denning, Warren
    Nilsson, Monique
    Poteete, Alissa
    Shen, Li
    Wang, Qi
    Guijarro, Irene
    Nichols, Keri
    Khairullah, Roohussaba
    Zhang, Jiexin
    Skoulidis, Ferdinandos
    Wang, Jing
    Wang, Linghua
    Heymach, John
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A960 - A960
  • [9] Heme sequestration modulates the tumor immune microenvironment in KRAS mutation/LKB1 inactivation non-small cell lung cancer
    Castro, Maria del Carmen Chacon
    Berisha, Eranda
    Salamat, Narges
    Zhang, Li
    CANCER RESEARCH, 2023, 83 (07)
  • [10] LKB1 deficiency is associated with a unique metabolic signature in Kras mutant non-small cell lung cancer (NSCLC)
    Liu, Tingyu
    Sennott, Erin
    Zhong, Zhengjie
    Steadman, Mya
    Marsh, Kelly
    Hurov, Jonathan
    Benes, Cyril
    Engelman, Jeffrey A.
    CANCER RESEARCH, 2016, 76
12345